OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
-1.82%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$136M
AUM Growth
+$136M
Cap. Flow
-$30M
Cap. Flow %
-22.11%
Top 10 Hldgs %
94.17%
Holding
14
New
2
Increased
1
Reduced
2
Closed
–

Top Buys

1
TBIO
Translate Bio, Inc. Common Stock
TBIO
$30.8M
2
KZR icon
Kezar Life Sciences
KZR
$12M
3
CDTX icon
Cidara Therapeutics
CDTX
$5.53M

Top Sells

1
EPIX icon
ESSA Pharma
EPIX
$78.3M
2
OBSV
ObsEva SA Ordinary Shares
OBSV
$5.09K

Sector Composition

1 Healthcare 97.98%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TBIO
1
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$30.8M 22.75% +2,437,601 New +$30.8M
PRTK
2
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$26.5M 19.57% 2,600,410 – –
OBSV
3
DELISTED
ObsEva SA Ordinary Shares
OBSV
$15.1M 11.17% 999,664 -336 -0% -$5.09K
KZR icon
4
Kezar Life Sciences
KZR
$28.9M
$12M 8.85% +693,272 New +$12M
SNNA
5
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$11.5M 8.5% 758,610 – –
FGEN icon
6
FibroGen
FGEN
$47.8M
$8.18M 6.03% 130,646 – –
CDTX icon
7
Cidara Therapeutics
CDTX
$1.66B
$7.85M 5.79% 1,508,794 +1,063,829 +239% +$5.53M
CBAY
8
DELISTED
Cymabay Therapeutics
CBAY
$7.4M 5.46% 551,477 – –
EPIX icon
9
ESSA Pharma
EPIX
$11.4M
$4.12M 3.04% 1,084,848 -20,612,121 -95% -$78.3M
JNCE
10
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$4.06M 3% 529,965 – –
PVLA
11
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$3.95M 2.91% 778,230 – –
DRNA
12
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2.74M 2.02% 223,457 – –
EGLT
13
DELISTED
Egalet Corporation
EGLT
$1.22M 0.9% 2,889,926 – –
JUNO
14
DELISTED
Juno Therapeutics, Inc.
JUNO
– – 0 – –